Skip to search boxSkip to navigationSkip to main content

cJun modulates Gγ-globin gene expression via an upstream cAMP response element

  • Sirisha Kodeboyina
    ,
  • Parimaladevi Balamurugan
    ,
  • Li Liu
    ,
  • Betty S. Pace(corresponding author)
*Corresponding author for this work
  • University of Texas at Dallas
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

The upstream Gγ-globin gene cAMP response element (G-CRE) was previously shown to play a role in drug-mediated fetal hemoglobin induction. This effect is achieved via p38 mitogen activated protein kinase (MAPK)-dependent CREB1 and ATF-2 phosphorylation and G-CRE transactivation. Since this motif is also a predicted consensus binding site for cJun we extended our analysis to determine the ability of cJun to transactivate γ-globin through the G-CRE. Using chromatin immunoprecipitation assays we showed comparable in vivo cJun and CREB1 binding to the G-CRE region. Protein-protein interactions were confirmed between cJun/ATF-2 and CREB1/ATF-2 but not between CREB1 and cJun. However, we observed cJun and CREB1 binding to the G-CRE in vitro by electrophoretic mobility shift assay. Promoter pull-down assay followed by sequential western blot analysis confirmed co-localization of cJun, CREB1, and ATF-2 on the G-CRE. To show functional relevance, enforced expression studies with pLen-cJun and a Gγ-promoter (- 1500 to + 36) luciferase reporter were completed; we observed a concentration-dependent increase in luciferase activity with pLen-cJun similar to that produced by CREB1 enforced expression. Moreover, the G/A mutation at -1225 in the G-CRE abolished cJun transactivation. Finally, enforced cJun expression in K562 cells and normal primary erythroid progenitors enhanced endogenous γ-globin gene expression. We conclude that these data indicate that cJun activates the Gγ-globin promoter via the G-CRE in a manner comparable with CREB1 and propose a model for γ-globin activation based on DNA-protein interactions in the G-CRE.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 7-15 (9 pages)

Journal (Volume, Issue Number)

Blood Cells, Molecules, and Diseases (Volume 44, Issue 1)

Publication milestones

  • Published - 01/2010

Publication status

Published - 01/2010

ISSN

1079-9796

Publication IDs

  • Scopus: 73049085606
  • PubMed: 19861239

Publication metrics

Metrics

SciVal
FWCI
0.70
SciVal
Author count
4
SciVal
citations
15
SciVal
Paper percentile
71
Scopus
citations
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
21
Captures
15

Funding Details

This work was supported by grant HL69234 from the National Heart Lung and Blood Institute and funding through the Center for Applied Biology at the University of Texas at Dallas to Betty S. Pace, MD.
FundersFunding number
Center for Applied Biology
-
NHLBI
R01HL069234
NHLI
-